MX2013005624A - Nuevos derivados de indolizina, su preparacion y su aplicacion en terapeutica. - Google Patents
Nuevos derivados de indolizina, su preparacion y su aplicacion en terapeutica.Info
- Publication number
- MX2013005624A MX2013005624A MX2013005624A MX2013005624A MX2013005624A MX 2013005624 A MX2013005624 A MX 2013005624A MX 2013005624 A MX2013005624 A MX 2013005624A MX 2013005624 A MX2013005624 A MX 2013005624A MX 2013005624 A MX2013005624 A MX 2013005624A
- Authority
- MX
- Mexico
- Prior art keywords
- therapeutic use
- preparation
- indolizine derivatives
- novel indolizine
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
La invención tiene por objeto derivados de indolizina de fórmula general (I), donde A, B, m, W, n y R2 son como se definen en la reivindicación 1, así como su procedimiento de preparación y su aplicación en terapéutica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1059445A FR2967412B1 (fr) | 2010-11-17 | 2010-11-17 | Nouveaux derives d'indolizine, leur preparation et leur application en therapeutique |
PCT/FR2011/052661 WO2012066234A1 (fr) | 2010-11-17 | 2011-11-16 | Nouveaux derives d'indolizine, leur préparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2013005624A true MX2013005624A (es) | 2013-07-05 |
Family
ID=43923771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013005624A MX2013005624A (es) | 2010-11-17 | 2011-11-16 | Nuevos derivados de indolizina, su preparacion y su aplicacion en terapeutica. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20130245006A1 (es) |
EP (1) | EP2640724A1 (es) |
JP (1) | JP2014500256A (es) |
KR (1) | KR20140014082A (es) |
CN (1) | CN103313986A (es) |
AU (1) | AU2011330996A1 (es) |
BR (1) | BR112013012300A2 (es) |
CA (1) | CA2818279A1 (es) |
FR (1) | FR2967412B1 (es) |
IL (1) | IL226388A0 (es) |
MX (1) | MX2013005624A (es) |
RU (1) | RU2013127239A (es) |
SG (1) | SG190825A1 (es) |
WO (1) | WO2012066234A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11919860B1 (en) | 2023-10-06 | 2024-03-05 | King Faisal University | 1-2(-(substituted phenyl)-2-oxoethyl)-4-(isopropoxycarbonyl)pyridin-1-ium bromides as anti-tubercular agents |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI61030C (fi) | 1976-02-19 | 1982-05-10 | Sanofi Sa | Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat |
FR2665444B1 (fr) * | 1990-08-06 | 1992-11-27 | Sanofi Sa | Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant. |
FR2838123B1 (fr) * | 2002-04-04 | 2005-06-10 | Sanofi Synthelabo | Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf |
FR2859997B1 (fr) * | 2003-09-18 | 2006-02-03 | Sanofi Synthelabo | Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant. |
FR2883286B1 (fr) * | 2005-03-16 | 2008-10-03 | Sanofi Aventis Sa | NOUVEAUX DERIVES D'IMIDAZO[1,5-a]PYRIDINES, INHIBITEURS DE FGFs, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT |
-
2010
- 2010-11-17 FR FR1059445A patent/FR2967412B1/fr not_active Expired - Fee Related
-
2011
- 2011-11-16 EP EP11796752.1A patent/EP2640724A1/fr not_active Withdrawn
- 2011-11-16 BR BR112013012300A patent/BR112013012300A2/pt not_active IP Right Cessation
- 2011-11-16 MX MX2013005624A patent/MX2013005624A/es not_active Application Discontinuation
- 2011-11-16 SG SG2013038138A patent/SG190825A1/en unknown
- 2011-11-16 AU AU2011330996A patent/AU2011330996A1/en not_active Abandoned
- 2011-11-16 WO PCT/FR2011/052661 patent/WO2012066234A1/fr active Application Filing
- 2011-11-16 KR KR1020137015316A patent/KR20140014082A/ko not_active Application Discontinuation
- 2011-11-16 CA CA2818279A patent/CA2818279A1/fr not_active Abandoned
- 2011-11-16 CN CN201180065218XA patent/CN103313986A/zh active Pending
- 2011-11-16 JP JP2013539312A patent/JP2014500256A/ja not_active Withdrawn
- 2011-11-16 RU RU2013127239/04A patent/RU2013127239A/ru not_active Application Discontinuation
- 2011-11-16 US US13/885,866 patent/US20130245006A1/en not_active Abandoned
-
2013
- 2013-05-16 IL IL226388A patent/IL226388A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2012066234A1 (fr) | 2012-05-24 |
JP2014500256A (ja) | 2014-01-09 |
FR2967412A1 (fr) | 2012-05-18 |
EP2640724A1 (fr) | 2013-09-25 |
KR20140014082A (ko) | 2014-02-05 |
RU2013127239A (ru) | 2014-12-27 |
IL226388A0 (en) | 2013-07-31 |
WO2012066234A9 (fr) | 2012-11-01 |
CN103313986A (zh) | 2013-09-18 |
SG190825A1 (en) | 2013-07-31 |
AU2011330996A1 (en) | 2013-06-06 |
CA2818279A1 (fr) | 2012-05-24 |
BR112013012300A2 (pt) | 2016-08-16 |
FR2967412B1 (fr) | 2012-12-14 |
US20130245006A1 (en) | 2013-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2576578A4 (en) | POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF | |
MY156938A (en) | Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application | |
TN2012000414A1 (en) | Forms of rifaximin and uses thereof | |
NZ603151A (en) | N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives | |
NZ597517A (en) | 5-fluoropyrimidinone derivatives | |
PH12015500376B1 (en) | Novel bicyclic pyridinones | |
PH12015501993A1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
UA114656C2 (uk) | Похідні піридину | |
PH12014501258A1 (en) | Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof | |
MX361413B (es) | Formas cristalinas de un macrólido y usos para las mismas. | |
IN2012DN03182A (es) | ||
PH12015501088A1 (en) | Dimeric compounds | |
MX2012013274A (es) | Novedosos derivados de la pirimidina. | |
MX2012007896A (es) | Derivados de piridino-piridinonas arilsulfonamidas, su preparacion y su uso en terapeutica. | |
JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof | |
UA110128C2 (uk) | Індолкарбоксаміди та бензімідазолкарбоксаміди як інсектициди та акарициди | |
MX349373B (es) | Nuevos derivados de pirazina. | |
NZ597570A (en) | N1-acyl-5-fluoropyrimidinone derivatives | |
IN2012DN01292A (es) | ||
MX2012010127A (es) | Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos. | |
IN2014DN10669A (es) | ||
PH12015500399A1 (en) | Azaindolines | |
IN2015DN00085A (es) | ||
MX349563B (es) | Formulacion farmaceutica de fenofibrato nanonizado. | |
MY160625A (en) | Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |